*  Exposure Controls/Personal Protection  *
Respiratory Protection:WEAR AN APPROVED RESPIRATOR IF THERE IS AN
    OPPORTUNITY FOR SPLASH, MIST/AEROSOL GENERATION.
Ventilation:LOCAL EXHAUST. (SEE SUPP)
Other Protective Equipment:CLOSED-FRONT GOWN W/KNIT CUFFS & MASKS
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
    REUSE. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
SPILLS CONT'D: VACUUM W/HEPA FILTERED & EXPLOSION PROOF EQUIPMENT/SCOOP
    UP & PLACE IN A SUITABLE CONTAINER. VENTILATION CONT'D: PREPARATION
    OF ALL ANTINEOPLASTIC AGENTS SHOULD BE DONE IN A CLASS II LA MINAR
    FLOW BIOLOGICAL SAFETY CABINET W/EXHAUST AIR DISCHARGED EXTERNAL TO
    ROOM ENVIRONMENT.
*  Product Identification  *
*  Composition/Information on Ingredients  *
Other REC Limits:2 UG/CUM
OSHA PEL:2 UG/CUM
ACGIH TLV:2 UG/CUM
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:NO  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:EYES/SKIN: IRRITATION. PRIMARY TOXIC
    EFFECT OF CYTARABINE IS BONE MARROW SUPPRESSION & LOSS OF IMMUNE
    RESPONSE. MASSIVE OVERDOSAGE HAS BEEN REPORTED TO CAUSE
    IRREVERSIBLE CNS DAMAGE. CYTARABINE IS KNO WN TO BE A TERATOGENIC.
    INTRAVENOUS HALF-LIFE OF CYTARABINE RANGES BETWEEN 1 & 3 HOURS.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION, ANOREXIA, NAUSEA, VOMITING,
    DIARRHEA, PROLONGED BLEEDING, INFECTIONS.
Medical Cond Aggravated by Exposure:HYPERSENSITIVITY TO CYTARABINE.
*  First Aid Measures  *
    INHALATION: REMOVE TO FRESH AIR. OBTAIN MEDICAL ATTENTION IN ALL
    CASES.
*  Fire Fighting Measures  *
Flash Point:NON-FLAMMABLE
Extinguishing Media:WATER, ALCOHOL FOAM, CO2, DRY CHEMICAL.
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS & FULL
    BODY PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:AS W/ALL FINELY DIVIDED ORGANIC POWDER,
    MAY FORM EXPLOSION HAZARDS.
*  Accidental Release Measures  *
Spill Release Procedures:REMOVE ALL IGNITION SOURCES. CONTROL
    GENERATION OF DUST/VAPORS. PROVIDE VENTILATION & PERSONAL
    PROTECTIVE EQUIPMENT. KEEP OUT OF DRAINS & PREVENT ENTRY TO SURFACE
    WATER, GROUNDWATER & SOIL. (SEE SUPP)
*Handling and Storage  *
Handling and Storage Precautions:STORE IN A COOL, DRY PLACE & PROTECT
    FROM LIGHT.
Other Precautions:AVOID CONTACT W/SKIN, EYES & CLOTHING. KEEP OUT OF
    REACH OF CHILDREN. GROUND ALL MECHANICAL EQUIPMENT TO PREVENT
    BUILDUP OF STATIC ELECTRICITY, INERT THE ATMOSPHERE & CONTROL DUST
    LEVELS.
*  Physical/Chemical Properties  *
Solubility in Water:COMPLETE
    PACKAGES W/NO ODOR.
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:STATIC ELECTRICITY, IGNITION SOURCES,
    LIGHT.
Hazardous Decomposition Products:CO, CO2, NITROGEN OXIDES.
*  Disposal Considerations  *
Waste Disposal Methods:ALL NEEDLES/SYRINGES/VIALS/AMPULE/OTHER
    EQUIPMENT/CLOTHING IN CONTACT W/CYTARABINE SHOULD BE SEGREGATED &
    CONTAINERS SHOULD BE OPENE D PRIOR TO INCINERATION.
